# A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques

> **NCT02350426** · PHASE1 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 10 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **OTHER:** Gadobutrol
- **OTHER:** 18F-FDG
- **OTHER:** 18F-GE-180

## Key facts

- **NCT ID:** NCT02350426
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-08-12
- **Primary completion:** 2016-10-26
- **Final completion:** 2016-10-26
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** A decision to stop the study was made by the site and GSK project team based on pre-defined stopping criteria in the protocol
- **Last updated:** 2017-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02350426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02350426, "A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02350426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*